Loading…
Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods
Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heteroge...
Saved in:
Published in: | BioMed research international 2022-12, Vol.2022, p.5297235-11 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013 |
---|---|
cites | cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013 |
container_end_page | 11 |
container_issue | |
container_start_page | 5297235 |
container_title | BioMed research international |
container_volume | 2022 |
creator | Ren, Jingxin Zhou, XianChao Guo, Wei Feng, KaiYan Huang, Tao Cai, Yu-Dong |
description | Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets. |
doi_str_mv | 10.1155/2022/5297235 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9812612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A732625484</galeid><sourcerecordid>A732625484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhYMozjDOzrUUuBG0ndyk8qiNMAw-BnoQbF2HVB7dGaqTNqlS-t-bstv2sTCbe3PzcXIPB6GngF8DMHZFMCFXjHSCUPYAnRMK7YJDCw9PPaVn6LKUe1yPBI47_hidUc6ho5ifI3NrXRyDD0aPIcUm-ebOjZv9cLiuwjrqccquNDra5tM01M6n3Kx0Nmmrm9XUj_tdHfb75k6bTYiuWTqdY4jrn0rJlifokddDcZfHeoG-vHv7-ebDYvnx_e3N9XJhWsHHRa-lw6SVvKurdx5kD61njGIhGAhHPeOY0OoVa2gJdFJa5ymxHKyzBAO9QG8Ourup3zprqrGsB7XLYavzXiUd1N8vMWzUOn1TnQTCgVSBF0eBnL5OroxqG4pxw6CjS1NRRHAiCTA8o8__Qe_TlGO1N1MghOgk-02t9eBUiD7Vf80sqq4FJZywVraVenWgTE6lZOdPKwNWc8xqjlkdY674sz9tnuBfoVbg5QGoaVj9Pfxf7gfasa0b</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761777985</pqid></control><display><type>article</type><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Online Library Journals Open Access</source><creator>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong</creator><contributor>Kim, Kwang Gi ; Kwang Gi Kim</contributor><creatorcontrib>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong ; Kim, Kwang Gi ; Kwang Gi Kim</creatorcontrib><description>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</description><identifier>ISSN: 2314-6133</identifier><identifier>ISSN: 2314-6141</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2022/5297235</identifier><identifier>PMID: 36619306</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Accuracy ; Adolescent ; Algorithms ; Annotations ; Biomarkers ; Cancer ; Chemical properties ; Child ; Classification ; Datasets ; Decision trees ; Deoxyribonucleic acid ; Diagnosis ; DNA ; DNA methylation ; DNA Methylation - genetics ; Epigenetics ; Ewings sarcoma ; Feature selection ; Gene expression ; Genetic aspects ; Health aspects ; Heterogeneity ; Humans ; Learning algorithms ; Machine Learning ; Medical diagnosis ; Metastases ; Methylation ; Oncology, Experimental ; Ranking ; Sarcoma ; Sarcoma - diagnosis ; Sarcoma - genetics ; Soft Tissue Neoplasms ; Solid tumors ; Therapeutic targets ; Tumors</subject><ispartof>BioMed research international, 2022-12, Vol.2022, p.5297235-11</ispartof><rights>Copyright © 2022 Jingxin Ren et al.</rights><rights>COPYRIGHT 2022 John Wiley & Sons, Inc.</rights><rights>Copyright © 2022 Jingxin Ren et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Jingxin Ren et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</citedby><cites>FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</cites><orcidid>0000-0003-1975-9693 ; 0000-0001-5664-7979</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2761777985/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2761777985?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36619306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kim, Kwang Gi</contributor><contributor>Kwang Gi Kim</contributor><creatorcontrib>Ren, Jingxin</creatorcontrib><creatorcontrib>Zhou, XianChao</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Feng, KaiYan</creatorcontrib><creatorcontrib>Huang, Tao</creatorcontrib><creatorcontrib>Cai, Yu-Dong</creatorcontrib><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</description><subject>Accuracy</subject><subject>Adolescent</subject><subject>Algorithms</subject><subject>Annotations</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Chemical properties</subject><subject>Child</subject><subject>Classification</subject><subject>Datasets</subject><subject>Decision trees</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnosis</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>Epigenetics</subject><subject>Ewings sarcoma</subject><subject>Feature selection</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Learning algorithms</subject><subject>Machine Learning</subject><subject>Medical diagnosis</subject><subject>Metastases</subject><subject>Methylation</subject><subject>Oncology, Experimental</subject><subject>Ranking</subject><subject>Sarcoma</subject><subject>Sarcoma - diagnosis</subject><subject>Sarcoma - genetics</subject><subject>Soft Tissue Neoplasms</subject><subject>Solid tumors</subject><subject>Therapeutic targets</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kUuLFDEUhYMozjDOzrUUuBG0ndyk8qiNMAw-BnoQbF2HVB7dGaqTNqlS-t-bstv2sTCbe3PzcXIPB6GngF8DMHZFMCFXjHSCUPYAnRMK7YJDCw9PPaVn6LKUe1yPBI47_hidUc6ho5ifI3NrXRyDD0aPIcUm-ebOjZv9cLiuwjrqccquNDra5tM01M6n3Kx0Nmmrm9XUj_tdHfb75k6bTYiuWTqdY4jrn0rJlifokddDcZfHeoG-vHv7-ebDYvnx_e3N9XJhWsHHRa-lw6SVvKurdx5kD61njGIhGAhHPeOY0OoVa2gJdFJa5ymxHKyzBAO9QG8Ourup3zprqrGsB7XLYavzXiUd1N8vMWzUOn1TnQTCgVSBF0eBnL5OroxqG4pxw6CjS1NRRHAiCTA8o8__Qe_TlGO1N1MghOgk-02t9eBUiD7Vf80sqq4FJZywVraVenWgTE6lZOdPKwNWc8xqjlkdY674sz9tnuBfoVbg5QGoaVj9Pfxf7gfasa0b</recordid><startdate>20221228</startdate><enddate>20221228</enddate><creator>Ren, Jingxin</creator><creator>Zhou, XianChao</creator><creator>Guo, Wei</creator><creator>Feng, KaiYan</creator><creator>Huang, Tao</creator><creator>Cai, Yu-Dong</creator><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1975-9693</orcidid><orcidid>https://orcid.org/0000-0001-5664-7979</orcidid></search><sort><creationdate>20221228</creationdate><title>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</title><author>Ren, Jingxin ; Zhou, XianChao ; Guo, Wei ; Feng, KaiYan ; Huang, Tao ; Cai, Yu-Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Accuracy</topic><topic>Adolescent</topic><topic>Algorithms</topic><topic>Annotations</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Chemical properties</topic><topic>Child</topic><topic>Classification</topic><topic>Datasets</topic><topic>Decision trees</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnosis</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>Epigenetics</topic><topic>Ewings sarcoma</topic><topic>Feature selection</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Learning algorithms</topic><topic>Machine Learning</topic><topic>Medical diagnosis</topic><topic>Metastases</topic><topic>Methylation</topic><topic>Oncology, Experimental</topic><topic>Ranking</topic><topic>Sarcoma</topic><topic>Sarcoma - diagnosis</topic><topic>Sarcoma - genetics</topic><topic>Soft Tissue Neoplasms</topic><topic>Solid tumors</topic><topic>Therapeutic targets</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, Jingxin</creatorcontrib><creatorcontrib>Zhou, XianChao</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Feng, KaiYan</creatorcontrib><creatorcontrib>Huang, Tao</creatorcontrib><creatorcontrib>Cai, Yu-Dong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, Jingxin</au><au>Zhou, XianChao</au><au>Guo, Wei</au><au>Feng, KaiYan</au><au>Huang, Tao</au><au>Cai, Yu-Dong</au><au>Kim, Kwang Gi</au><au>Kwang Gi Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2022-12-28</date><risdate>2022</risdate><volume>2022</volume><spage>5297235</spage><epage>11</epage><pages>5297235-11</pages><issn>2314-6133</issn><issn>2314-6141</issn><eissn>2314-6141</eissn><abstract>Sarcoma, the second common type of solid tumor in children and adolescents, has a wide variety of subtypes that are often not properly diagnosed at an early stage, leading to late metastases and causing serious loss of life and property to patients and families. It exhibits a high degree of heterogeneity at the cellular, molecular, and epigenetic levels, where DNA methylation has been proposed to play a role in the diagnosis of sarcoma subtypes. Thus, this study is aimed at finding potential biomarkers at the DNA methylation level to distinguish different sarcoma subtypes. A machine learning process was designed to analyse sarcoma samples, each of which was represented by lots of methylation sites. Irrelevant sites were removed using the Boruta method, and remaining sites related to the target variables were kept for further analyses. Afterward, three feature ranking methods (LASSO, LightGBM, and MCFS) were adopted to rank these features, and six classification models were constructed by combining incremental feature selection and two classification algorithms (decision tree and random forest). Among these models, the performance of RF model was higher than that of DT model under all three ranking conditions. The specific expression of genes obtained from the annotation of highly correlated methylation site features, such as PRKAR1B, INPP5A, and GLI3, was proven to be associated with sarcoma by publications. Moreover, the quantitative rules obtained by decision tree algorithm helped us to understand the essential differences between various sarcoma types and classify sarcoma subtypes, providing a new means of clinical identification and determining new therapeutic targets.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>36619306</pmid><doi>10.1155/2022/5297235</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1975-9693</orcidid><orcidid>https://orcid.org/0000-0001-5664-7979</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2022-12, Vol.2022, p.5297235-11 |
issn | 2314-6133 2314-6141 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9812612 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Online Library Journals Open Access |
subjects | Accuracy Adolescent Algorithms Annotations Biomarkers Cancer Chemical properties Child Classification Datasets Decision trees Deoxyribonucleic acid Diagnosis DNA DNA methylation DNA Methylation - genetics Epigenetics Ewings sarcoma Feature selection Gene expression Genetic aspects Health aspects Heterogeneity Humans Learning algorithms Machine Learning Medical diagnosis Metastases Methylation Oncology, Experimental Ranking Sarcoma Sarcoma - diagnosis Sarcoma - genetics Soft Tissue Neoplasms Solid tumors Therapeutic targets Tumors |
title | Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Methylation%20Signatures%20and%20Rules%20for%20Sarcoma%20Subtypes%20by%20Machine%20Learning%20Methods&rft.jtitle=BioMed%20research%20international&rft.au=Ren,%20Jingxin&rft.date=2022-12-28&rft.volume=2022&rft.spage=5297235&rft.epage=11&rft.pages=5297235-11&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2022/5297235&rft_dat=%3Cgale_pubme%3EA732625484%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c476t-ba8e0248692319f18b14f553077517e3f560232970a1421988def32d61ded2013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2761777985&rft_id=info:pmid/36619306&rft_galeid=A732625484&rfr_iscdi=true |